RY
RYLPF
KONINKLIJKE PHILIPS NV
$26.06
0.00%
No data for this timeframe.
Vol
SEC Reports4
Exchange OTC·Sector X-Ray Apparatus & Tubes & Related Irradiation Apparatus·Inc. P7·CIK 0000313216·Prev Close $26.06
Recent Activity
Jun 2, 2026
SEC
Philips announced the exchange ratio for its 2025 dividend: 1 new share per 26.9341 existing shares, resulting in ~19.96
6-K — Impact 2/10
May 8, 2026
SEC
Philips shareholders approved all proposals at the 2026 AGM, including the re-appointment of CEO Roy Jakobs and the appo
6-K — Impact 2/10
Mar 30, 2026
SEC
Royal Philips convened its 2026 Annual General Meeting of Shareholders, announcing board appointments and re-appointment
6-K — Impact 3/10
Analyst Ratings
6Strong Buy
10Buy
13Hold
0Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 2.5/10.
NEUTRAL
6-K
2/10
Philips announced the exchange ratio for its 2025 dividend: 1 new share per 26.9341 existing shares,
Jun 2, 2026
NEUTRAL
6-K
2/10
Philips shareholders approved all proposals at the 2026 AGM, including the re-appointment of CEO Roy
May 8, 2026
NEUTRAL
6-K
3/10
Royal Philips convened its 2026 Annual General Meeting of Shareholders, announcing board appointment
Mar 30, 2026
NEUTRAL
6-K
3/10
Philips announced proposed appointments and re-appointments to its Supervisory Board, including John
Mar 30, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 55% buy across 29 analysts — 6 strong buy, 10 buy, 13 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $4.3B | -0.6% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $4.4B | 3.1% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $18.0B | 0.9% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $18.8B | 4.4% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 10 | 13 | 0 | 0 | 55% | |
| May 1, 2026 | 6 | 11 | 13 | 0 | 0 | 57% | |
| Apr 1, 2026 | 6 | 10 | 14 | 0 | 0 | 53% | |
| Mar 1, 2026 | 6 | 11 | 13 | 0 | 0 | 57% | |
| Feb 1, 2026 | 5 | 10 | 15 | 0 | 0 | 50% | |
| Jan 1, 2026 | 4 | 9 | 15 | 0 | 0 | 46% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.